The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...
Copycat versions of Eli Lilly’s diabetes drug Mounjaro and obesity drug Zepbound were supposed to go away this week. They’re ...
While the number of prescription fills for GLP-1 receptor agonists has continued to increase, health Insurance coverage for ...
This week was supposed to mark the end of compounding pharmacies making copycat versions of Eli Lilly's weight-loss drug Zepbound and its diabetes drug Mounjaro. Online, it doesn't look like much ...